Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Jordan Deaner
Vaidehi S. Dedania, MD
Rehan M. Hussain, MD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
International Congress of Scleral Contacts (ICSC) 2026
June 05, 2026
San Diego, California
MH Risk Factors After RRD Repair
Maria H. Berrocal, MD
Avni P. Finn, MD, MBA
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
Katherine E. Talcott, MD
Christina Y. Weng, MD, MBA, FASRS
Roger A. Goldberg, MD, MBA
Identifying Central and Branch Retinal Vein Occlusion
Jessica Randolph, MD
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Ashkan Abbey, MD
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Trends in PDR Treatments
Katharine Talcott, MD
Outcomes for PDR Patients LTFU for at Least 1 Year
Kyle Davis Kovacs, MD
Matt Starr, MD
Nita Valikodath, MD, MS
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Danny Mammo, MD
Practice Efficiency and Innovation
Jacob Lang
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.